Market
BSE Prices delayed by 5 minutes... << Prices as on Dec 15, 2025 - 11:14AM >>  ABB India  5247.85 [ -0.51% ] ACC  1779.6 [ 0.45% ] Ambuja Cements  553.1 [ 0.92% ] Asian Paints Ltd.  2795.35 [ 1.08% ] Axis Bank Ltd.  1286.2 [ -0.01% ] Bajaj Auto  8903 [ -1.23% ] Bank of Baroda  283.65 [ -0.30% ] Bharti Airtel  2068 [ -0.74% ] Bharat Heavy Ele  282.4 [ -1.05% ] Bharat Petroleum  366.55 [ 0.48% ] Britannia Ind.  6023 [ 1.82% ] Cipla  1512.5 [ -0.31% ] Coal India  383.25 [ -0.01% ] Colgate Palm  2166.05 [ 0.27% ] Dabur India  497.35 [ 0.55% ] DLF Ltd.  693.25 [ -0.89% ] Dr. Reddy's Labs  1271.1 [ -0.67% ] GAIL (India)  169.9 [ -0.53% ] Grasim Inds.  2822.9 [ -0.50% ] HCL Technologies  1681.1 [ 0.52% ] HDFC Bank  995.3 [ -0.49% ] Hero MotoCorp  5916.6 [ -0.71% ] Hindustan Unilever L  2278.25 [ 0.76% ] Hindalco Indus.  846.55 [ -0.67% ] ICICI Bank  1363.95 [ -0.15% ] Indian Hotels Co  735.3 [ 0.07% ] IndusInd Bank  842.6 [ -0.37% ] Infosys L  1603.4 [ 0.29% ] ITC Ltd.  402.3 [ 0.45% ] Jindal Steel  1024.3 [ -0.51% ] Kotak Mahindra Bank  2163.5 [ -0.60% ] L&T  4076.35 [ 0.07% ] Lupin Ltd.  2091.5 [ -1.07% ] Mahi. & Mahi  3625.2 [ -1.46% ] Maruti Suzuki India  16430.65 [ -0.55% ] MTNL  36.39 [ -1.22% ] Nestle India  1245 [ 0.55% ] NIIT Ltd.  89.7 [ 1.67% ] NMDC Ltd.  77.66 [ -0.32% ] NTPC  324.05 [ -0.31% ] ONGC  232.45 [ -2.35% ] Punj. NationlBak  117.2 [ -0.51% ] Power Grid Corpo  262.05 [ -0.59% ] Reliance Inds.  1550.8 [ -0.33% ] SBI  960.25 [ -0.28% ] Vedanta  541.9 [ -0.30% ] Shipping Corpn.  223.05 [ -1.06% ] Sun Pharma.  1785.6 [ -0.48% ] Tata Chemicals  759.7 [ 0.11% ] Tata Consumer Produc  1165.5 [ 1.41% ] Tata Motors Passenge  344.55 [ -0.83% ] Tata Steel  172.35 [ 0.26% ] Tata Power Co.  379.45 [ -0.64% ] Tata Consultancy  3227 [ 0.21% ] Tech Mahindra  1582.8 [ 0.24% ] UltraTech Cement  11715 [ -0.09% ] United Spirits  1443.75 [ -0.22% ] Wipro  260.8 [ 0.10% ] Zee Entertainment En  93.8 [ -0.48% ] 
Krishna Institute of Medical Sciences Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 26303.13 Cr. P/BV 13.14 Book Value (Rs.) 50.03
52 Week High/Low (Rs.) 798/474 FV/ML 2/1 P/E(X) 68.41
Bookclosure 13/09/2024 EPS (Rs.) 9.61 Div Yield (%) 0.00
Year End :2025-03 

We have audited the standalone financial statements of
Krishna Institute of Medical Sciences Limited (“the
Company”), which comprise the Balance sheet as at March
31 2025, the Statement of Profit and Loss, including the
statement of Other Comprehensive Income, the Cash Flow
Statement and the Statement of Changes in Equity for the year
then ended, and notes to the standalone financial statements,
including a summary of material accounting policies and other
explanatory information.

In our opinion and to the best of our information and according
to the explanations given to us, the aforesaid standalone
financial statements give the information required by the
Companies Act, 2013, as amended (“the Act”) in the manner
so required and give a true and fair view in conformity with the
accounting principles generally accepted in India, of the state of
affairs of the Company as at March 31,2025, its profit including
other comprehensive income, its cash flows and the changes in
equity for the year ended on that date.

Basis for Opinion

We conducted our audit of the standalone financial statements
in accordance with the Standards on Auditing (SAs), as specified
under section 143(10) of the Act. Our responsibilities under those
Standards are further described in the ‘Auditor’s Responsibilities
for the Audit of the Standalone Financial Statements’ section of
our report. We are independent of the Company in accordance
with the ‘Code of Ethics’ issued by the Institute of Chartered

Accountants of India together with the ethical requirements that
are relevant to our audit of the financial statements under the
provisions of the Act and the Rules thereunder, and we have
fulfilled our other ethical responsibilities in accordance with
these requirements and the Code of Ethics. We believe that the
audit evidence we have obtained is sufficient and appropriate
to provide a basis for our audit opinion on the standalone
financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional
judgment, were of most significance in our audit of the
standalone financial statements for the financial year ended
March 31, 2025. These matters were addressed in the context
of our audit of the standalone financial statements as a whole,
and in forming our opinion thereon, and we do not provide a
separate opinion on these matters. For each matter below, our
description of how our audit addressed the matter is provided
in that context.

We have determined the matters described below to be the key
audit matters to be communicated in our report. We have fulfilled
the responsibilities described in the Auditor’s responsibilities
for the audit of the standalone financial statements section of
our report, including in relation to these matters. Accordingly,
our audit included the performance of procedures designed to
respond to our assessment of the risks of material misstatement
of the standalone financial statements. The results of our audit
procedures, including the procedures performed to address the
matters below, provide the basis for our audit opinion on the
accompanying standalone financial statements.

Key audit matters

How our audit addressed the key audit matter

Impairment assessment of Investments in and Loans to subsidiaries (Sarvejana Healthcare Private Limited, KIMS Hospital
Enterprises Private Limited and Spanv Medisearch Lifesciences Private Limited)
(as described in Note 2.2 and 2.3 of the

standalone financial statements)

As at March 31,2025, the Company has investments in Sarvejana
Healthcare Private Limited, KIMS Hospital Enterprises Private
Limited and Spanv Medisearch Lifesciences Private Limited
amounting to Rs. 6,310 million, Rs. 1,546 million and Rs. 1,571
million respectively carried at cost. Further, the Company has
granted loans to above subsidiaries amounting to Rs. 204 million.
The investments/loans are tested annually for impairment using
discounted cash-flow models by which recoverable value is
compared to the carrying value as at balance sheet date. A deficit
between the recoverable value and the carrying value would
result in impairment

The inputs to the impairment testing model include:

- Projected revenue growth, operating margins, operating cash¬
flows and capex during the periods related to explicit forecast;

Our audit procedures included the following:

• We tested the design, implementation and operative
effectiveness of management’s key internal controls over
impairment assessments;

• We gained an understanding of and evaluated the
methodology used by management to prepare its
cash flow forecasts and the appropriateness of the
assumptions applied.

• We evaluated the assumptions around the key drivers
of the cash flow forecasts including discount rates,
expected growth rates and terminal growth rates used; in
consideration of the current and estimated future economic
conditions; and tested the arithmetical accuracy of model;

Key audit matters

How our audit addressed the key audit matter

- Stable long-term growth rates beyond explicit forecast period
and in perpetuity; and

- Discount rates that represent the current market assessment
of the risks specific to the business, taking into consideration
the time value of money (pre-tax).

The financial projections, basis which the future cash flows
have been estimated, consider the impact of the economic
uncertainties on the discount rates, the projected growth rates
and terminal values and subjecting these variables to sensitivity
analysis.

The annual impairment testing of these subsidiaries is considered
a key audit matter because the assumptions on which the tests
are based are highly judgmental and are affected by future
market and economic conditions which are inherently uncertain,
and because of the materiality of the balances to the Standalone
Financial Statements as a whole

• We tested budgeting procedures upon which the cash flow
forecasts were based. We have also compared the actual
past performances with the budgeted figures

• We assessed the recoverable value headroom by performing
sensitivity testing of key assumptions used;

• We assessed the adequacy of the related disclosures in
notes to the Standalone Financial Statements.

Other Information

The Company’s Board of Directors is responsible for the other
information. The other information comprises the information
included in the Annual report, but does not include the standalone
financial statements and our auditor’s report thereon.

Our opinion on the standalone financial statements does not
cover the other information and we do not express any form of
assurance conclusion thereon.

In connection with our audit of the standalone financial
statements, our responsibility is to read the other information
and, in doing so, consider whether such other information is
materially inconsistent with the financial statements or our
knowledge obtained in the audit or otherwise appears to be
materially misstated. If, based on the work we have performed,
we conclude that there is a material misstatement of this other
information, we are required to report that fact. We have nothing
to report in this regard.

Responsibilities of Management for the Standalone
Financial Statements

The Company’s Board of Directors is responsible for the matters
stated in section 134(5) of the Act with respect to the preparation
of these standalone financial statements that give a true and fair
view of the financial position, financial performance including
other comprehensive income, cash flows and changes in equity
of the Company in accordance with the accounting principles
generally accepted in India, including the Indian Accounting
Standards (Ind AS) specified under section 133 of the Act read
with the Companies (Indian Accounting Standards) Rules, 2015,
as amended. This responsibility also includes maintenance of
adequate accounting records in accordance with the provisions
of the Act for safeguarding of the assets of the Company and
for preventing and detecting frauds and other irregularities;
selection and application of appropriate accounting policies;
making judgments and estimates that are reasonable and
prudent; and the design, implementation and maintenance

of adequate internal financial controls, that were operating
effectively for ensuring the accuracy and completeness of the
accounting records, relevant to the preparation and presentation
of the standalone financial statements that give a true and fair
view and are free from material misstatement, whether due to
fraud or error.

In preparing the standalone financial statements, management
is responsible for assessing the Company’s ability to continue
as a going concern, disclosing, as applicable, matters related to
going concern and using the going concern basis of accounting
unless management either intends to liquidate the Company or
to cease operations, or has no realistic alternative but to do so.

Those charged with governance are also responsible for
overseeing the Company’s financial reporting process.

Auditor’s Responsibilities for the Audit of the
Standalone Financial Statements

Our objectives are to obtain reasonable assurance about
whether the standalone financial statements as a whole are free
from material misstatement, whether due to fraud or error, and to
issue an auditor’s report that includes our opinion. Reasonable
assurance is a high level of assurance, but is not a guarantee
that an audit conducted in accordance with SAs will always
detect a material misstatement when it exists. Misstatements
can arise from fraud or error and are considered material if,
individually or in the aggregate, they could reasonably be
expected to influence the economic decisions of users taken on
the basis of these standalone financial statements.

As part of an audit in accordance with SAs, we exercise
professional judgment and maintain professional skepticism
throughout the audit. We also:

• Identify and assess the risks of material misstatement of
the standalone financial statements, whether due to fraud
or error, design and perform audit procedures responsive
to those risks, and obtain audit evidence that is sufficient

and appropriate to provide a basis for our opinion. The
risk of not detecting a material misstatement resulting
from fraud is higher than for one resulting from error, as
fraud may involve collusion, forgery, intentional omissions,
misrepresentations, or the override of internal control.

• Obtain an understanding of internal control relevant to
the audit in order to design audit procedures that are
appropriate in the circumstances. Under section 143(3)
(i) of the Act, we are also responsible for expressing our
opinion on whether the Company has adequate internal
financial controls with reference to financial statements in
place and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used
and the reasonableness of accounting estimates and
related disclosures made by management.

• Conclude on the appropriateness of management’s use of
the going concern basis of accounting and, based on the
audit evidence obtained, whether a material uncertainty
exists related to events or conditions that may cast
significant doubt on the Company’s ability to continue as a
going concern. If we conclude that a material uncertainty
exists, we are required to draw attention in our auditor’s
report to the related disclosures in the financial statements
or, if such disclosures are inadequate, to modify our
opinion. Our conclusions are based on the audit evidence
obtained up to the date of our auditor’s report. However,
future events or conditions may cause the Company to
cease to continue as a going concern.

• Evaluate the overall presentation, structure and content
of the standalone financial statements, including the
disclosures, and whether the standalone financial
statements represent the underlying transactions and
events in a manner that achieves fair presentation.

We communicate with those charged with governance regarding,
among other matters, the planned scope and timing of the
audit and significant audit findings, including any significant
deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement
that we have complied with relevant ethical requirements
regarding independence, and to communicate with them
all relationships and other matters that may reasonably be
thought to bear on our independence, and where applicable,
related safeguards.

From the matters communicated with those charged with
governance, we determine those matters that were of most
significance in the audit of the standalone financial statements
for the financial year ended March 31, 2025 and are therefore
the key audit matters. We describe these matters in our auditor’s
report unless law or regulation precludes public disclosure
about the matter or when, in extremely rare circumstances, we
determine that a matter should not be communicated in our
report because the adverse consequences of doing so would
reasonably be expected to outweigh the public interest benefits
of such communication.

Report on Other Legal and Regulatory
Requirements

1. As required by the Companies (Auditor’s Report) Order,
2020 (“the Order”), issued by the Central Government of
India in terms of sub-section (11) of section 143 of the Act,
we give in the “
Annexure 1 ” a statement on the matters
specified in paragraphs 3 and 4 of the Order.

2. As required by Section 143(3) of the Act, we report, to the
extent applicable, that:

(a) We have sought and obtained all the information and
explanations which to the best of our knowledge and
belief were necessary for the purposes of our audit;

(b) In our opinion, proper books of account as required
by law have been kept by the Company so far as it
appears from our examination of those books except
for the matters stated in the paragraph 2(i)(vi) below
on reporting under Rule 11(g);

(c) The Balance Sheet, the Statement of Profit and Loss
including the Statement of Other Comprehensive
Income, the Cash Flow Statement and Statement
of Changes in Equity dealt with by this Report are in
agreement with the books of account;

(d) In our opinion, the aforesaid standalone financial
statements comply with the Accounting Standards
specified under Section 133 of the Act, read with
Companies (Indian Accounting Standards) Rules,
2015, as amended;

(e) On the basis of the written representations received
from the directors as on March 31, 2025 taken on
record by the Board of Directors, none of the directors is
disqualified as on March 31,2025 from being appointed
as a director in terms of Section 164 (2) of the Act;

(f) With respect to the adequacy of the internal financial controls
with reference to these standalone financial statements and
the operating effectiveness of such controls, refer to our
separate Report in “
Annexure 2” to this report;

(g) In our opinion, the managerial remuneration for the
year ended March 31, 2025 has been paid / provided
by the Company to its directors in accordance
with the provisions of section 197 read with
Schedule V to the Act;

(h) The modifications relating to the maintenance of
accounts and other matters connected therewith are
as stated in the paragraph 2(b) above on reporting
under Section 143(3)(b) and paragraph 2(i)(vi) below
on reporting under Rule 11(g);

(i) With respect to the other matters to be included
in the Auditor’s Report in accordance with Rule
11 of the Companies (Audit and Auditors) Rules,
2014, as amended in our opinion and to the
best of our information and according to the
explanations given to us:

i. The Company has disclosed the impact of
pending litigations on its financial position in its
standalone financial statements - Refer Note
2.25 to the standalone financial statements;

ii. The Company did not have any long-term
contracts including derivative contracts for which
there were any material foreseeable losses;

iii. There were no amounts which were required
to be transferred to the Investor Education and
Protection Fund by the Company.

iv. a) The management has represented that,

to the best of its knowledge and belief,
no funds have been advanced or loaned
or invested (either from borrowed funds
or share premium or any other sources
or kind of funds) by the Company to or in
any other person(s) or entity(ies), including
foreign entities (“Intermediaries”), with
the understanding, whether recorded in
writing or otherwise, that the Intermediary
shall, whether, directly or indirectly lend or
invest in other persons or entities identified
in any manner whatsoever by or on behalf
of the Company (“Ultimate Beneficiaries”)
or provide any guarantee, security or the
like on behalf of the Ultimate Beneficiaries;

b) The management has represented that, to
the best of its knowledge and belief, no
funds have been received by the Company
from any person(s) or entity(ies), including
foreign entities (“Funding Parties”), with the
understanding, whether recorded in writing
or otherwise, that the Company shall,
whether, directly or indirectly, lend or invest
in other persons or entities identified in any
manner whatsoever by or on behalf of the
Funding Party (“Ultimate Beneficiaries”) or
provide any guarantee, security or the like
on behalf of the Ultimate Beneficiaries; and

c) Based on such audit procedures performed
that have been considered reasonable and
appropriate in the circumstances, nothing
has come to our notice that has caused
us to believe that the representations
under sub-clause (a) and (b) contain any
material misstatement.

v. No dividend has been declared or paid during
the year by the Company.

vi. Based on our examination which included test
checks, the Company has used accounting
software for maintaining its books of accounts
which has a feature of recording audit trail
(edit log) facility and the same has operated
throughout the year for all relevant transactions
recorded in the software, except in respect of
one accounting software where audit trail feature
is not enabled for direct changes to data when
using certain access rights from April 01, 2024
to March 25, 2025, as described in note 2.38
to the financial statements. Further, during the
course of our audit, we did not come across any
instance of audit trail feature being tampered with
in respect of the accounting software used where
the audit trail has been enabled. Additionally, the
audit trail of the prior year has been preserved by
the Company as per the statutory requirements
for record retention to the extent it was enabled
and recorded in the respective year.

For S.R. Batliboi & Associates LLP

Chartered Accountants
ICAI Firm Registration Number: 101049W/E300004

per Navneet Rai Kabra

Partner

Place of Signature: Hyderabad Membership Number: 102328
Date: May 12, 2025 UDIN: 25102328BMOPZN3613


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by